Shawn Rose
Seminars
Wednesday 3rd December 2025
Optimizing Immune Cell Target Selection to Deliver Effective Autoimmune Therapies
11:30 am
- Evaluate which immune cell targets have demonstrated the greatest therapeutic benefits to guide treatment decisions
- Understand patient tolerance to targeting alternative immune cells to optimize safety and efficacy
- Leverage insights from Nkarta Therapeutics’ NK cell-based Non-Hodgkins Lymphoma therapy to predict autoimmune success
